Related Experiment Video

Updated: Jun 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib

Fabio P S Santos, Morgani Rodrigues, Claudia Mac-Donald Bley do Nascimento

    Cytotherapy
    |November 3, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    Related Experiment Videos

    Last Updated: Jun 19, 2026

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Predicting 30-day unplanned readmissions in patients with cancer in a Brazilian hospital: a Machine Learning approach.

    Einstein (Sao Paulo, Brazil)·2026

    Photobiomodulation to minimize talquetamab-associated dysgeusia and xerostomia in multiple myeloma: a brief report of four cases.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

    False-positive test results: prevalence, time trends, and factors associated with false-positive serological markers in blood donation screening.

    Hematology, transfusion and cell therapy·2026

    Prophylaxis of graft-versus-host-disease: Systematic evidence-based recommendations of the Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and the Brazilian society of cellular therapy and bone marrow transplantation (SBTMO).

    Hematology, transfusion and cell therapy·2026

    Comparison of Carmustine-, Lomustine-, and Nitrosourea-Free Conditioning Regimens for Autologous HCT (Auto-HCT) in Lymphoma: Results From the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR).

    Transplantation and cellular therapy·2026

    Oral manifestations and dental management in patients undergoing CAR-T cell therapy: a retrospective observational study.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

    WJ-MSCs modulate Treg phenotypic and transcriptional profiles in T1DM: comparative insights into direct and indirect mechanisms.

    Cytotherapy·2026

    Multicenter validation study on post-thaw viability testing of cryopreserved hematopoietic progenitor cell products.

    Cytotherapy·2026

    Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

    Cytotherapy·2026

    From classroom to cleanroom: building a skilled cell and gene therapy workforce.

    Cytotherapy·2026

    The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee.

    Cytotherapy·2026

    MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.

    Cytotherapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us